05:01 PM EDT, 09/30/2024 (MT Newswires) -- Quanterix ( QTRX ) said Monday that its Simoa p-Tau 217 Planar Kit for Alzheimer's Disease testing is now commercially available for clinical research use.

The blood test kit combines Eli Lilly's ( LLY ) p-Tau 217 antibody technology and Quanterix ( QTRX )' SP-X platform.

Shares of Quanterix ( QTRX ) were down more than 5% in after-hours activity.

Price: 12.28, Change: -0.68, Percent Change: -5.28